Trademark Search in Canada

RECURSION

View On IC.GC.CA

REGISTERED

on 5 Feb 2024

Last Applicant/ Owned by

RECURSION PHARMACEUTICALS INC.

41 South Rio Grande StreetSalt Lake City UT 84101

Serial Number

2113295 filed on 28^th Apr 2021

Registration Number

TMA1220373 registered on 5^th Feb 2024

Registration expiry Date

28^th Apr 2031

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

M5E1G4

RECURSION

Trademark usage description

computer software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious Read More

Classification Information

Class [009]
Computer software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases, to prescribe medical treatment for blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze patient medical information, and to develop pharmaceutical products and chemical compounds for diagnosing and treating blood disorders, rare genetic disorders, and infectious diseases.

Classification kind code

Class [042]
Scientific and technological services, namely, medical research laboratory services, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases, to prescribe medical treatment for blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze patient medical information, and to develop pharmaceutical products and chemical compounds for diagnosing and treating blood disorders, rare genetic disorders, and infectious diseases; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; drug use discovery services.

Classification kind code

Mark Details

Serial Number

2113295

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 13^th Oct 2022	Agent Changed
Submitted for opposition 22 on 15^th Sept 2022	Search Recorded
Submitted for opposition 20 on 15^th Sept 2022	Examiner's First Report
Submitted for opposition 223 on 15^th Sept 2022	Total Provisional Refusal
Submitted for opposition 256 on 11^th Apr 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 10^th Jun 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 9^th Jun 2021	Formalized
Submitted for opposition 1 on 9^th Jun 2021	Created
Submitted for opposition 228 on 28^th Apr 2021	International Registration
Submitted for opposition 30 on 28^th Apr 2021	Filed